Phase 1b Dose Escalation Study of Intravenous JX-594 in Metastatic, Refractory Colorectal Carcinoma
Clinical trial NCT01380600 · COMPLETED
Trial details
- NCT number
- NCT01380600
- Sponsor
- Jennerex Biotherapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-08
- Primary completion
- 2012-10-18
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.